This all sounds like a big wonderful hug fest & one giant "can't we all just get along" moment for all those that have been watching these corporate crimes being waged against society and humanity go unchecked for decades now. But the caution bells are ringing in distance as we have learned the hard way many times before with Big Pharma; words are always cheap, while honesty & accountability is something of an abomination to the holy pharmaceutical corporate stone tablet creed.
So as they say, the proof will lay/lie in the pudding. Will AstraZeneca finally do the right thing when it's comes to the many thousands injured by Seroquel, will J&J make good on the Risperdal crime settlements and get clean/sober, will GSK come in with a apology mop with groveling pledges of restitution and pay outs for damage caused by Paxil, Wellbutrin, Avandia, as we just name a few of the many ongoing Big Pharma Cartel horrendous criminal actions that have seriously harmed or killed consumers.
If you believe the sweet smell of change is in the air, you might want to ask/consider why is Big Pharma trying to close the honesty door at the same time they are saying they want it to be wide open? read here-->And Here Is The SEC Whistleblower Program
Or here where they continue funding front marketing groups - AstraZeneca Funds DBSA http://www.speakaboutdepression.com/ and AstraZeneca funds NAMI -http://www.namimi.org/astrazeneca-bipolar-journey-exhibit-appearing-2010-nami-walks as stellar examples.
One might/would get the distinct impression that Big Pharma has no intention of changing their profitable criminal ways, or their seedy business as usual model. Definitely give us all some food for thought as the DOJ finally appears on it's face to be taking some substantive action against the world largest criminal organization.
via coreynahman.com & pharmagossip
Former Glaxo Lawyer/Exec Indicted For Obstruction
Move telegraphs DOJ's posture regarding going after execs:
Former Glaxo Lawyer Charged With Obstruction of Probe … lying to obstruct a U.S. investigation into whether the pharmaceutical company illegally marketed an antidepressant as a weight-loss drug. …[Wall Street Journal]
Former Glaxo lawyer accused of marketing cover-up … concealing evidence and falsifying documents to influence a federal agency, four counts of making false statements to the FDA, as well as one count of obstructing an official proceeding …[MM&M]
Ex-Glaxo Lawyer Indicted for Role in US Drug Probe … withholding slides that were used by doctors who were paid by Glaxo to promote the drug and that she prepared a memorandum about …[US News]
DOJ charges former Glaxo lawyer with obstruction … rare case of the Department of Justice targeting a specific executive, rather than an entire company … obstructing justice and making false statements in an effort to conceal illegal promotion of a company drug …
It's titillating she is a lawyer but the real take home point is that the US Attorney has indicted a former V.P. (She is retired). The shit is going to hit the fan when they offer her immunity to tell on her friends. (And you know she will because there is no parole in Federal prisons). Worst case scenario would be that she implicates her former compadres in a manner that morphs this headache into a full blown RICO case.
And bnet-pharma Jim Edwards has his take on this developing news
Indicted Glaxo Lawyer’s Choice: Cooperate With Feds or Stay SilentA vp/associate general counsel at GlaxoSmithKline (GSK) was indicted for lying to the FDA in a signal that the feds have finally begun their long-awaited quest to prosecute individual drug executives for wrongdoing in the drug business. Previously, prosecutors relied on multimillion dollar settlements in their attempts to discipline drug companies. Those settlements merely became part of Big Pharma’s revenue model, however, so now they’re going after management.
Prosecutors have started at Big Pharma’s weakest point: GSK. The company recently settled a $750 million case in which the feds discovered workers at its Paxil factory in Puerto Rico were running a black market drugs operation, shipping contaminated or mixed-up pills, and filing reports in Spanish so that management couldn’t understand them. The Paxil fiasco is still under scrutiny: Congress has demanded a probe of the FDA in Puerto Rico to understand why the agency was asleep at the wheel during the 10 years that the GSK facility ran of the rails. At the time of the Paxil settlement, the U.S. Attorney’s Office in Boston said the Paxil probe was still “ongoing.”Which brings us to the accused GSK lawyer, Lauren Stevens, and what will happen next. Stevens has been indicted for alleged misstatements she made to the FDA about GSK’s promotion of the antidepressant Wellbutrin. GSK paid 2,700 doctors to give promotional talks about the drug and Stevens knew 28 of them were using materials promoting illegal, “off-label” uses of the drug for purposes such as weight loss, the indictment claims. The probe began in 2002, according to page 144 of this GSK disclosure.